Gene · 8835
Papers2,451
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,451
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Computational Investigation Revealing the Mechanisms of Photoisomerization, Amide Formation, and Spin-Trapping of a Ribonucleoside-Derived Nitrone. | J Phys Chem A | 2026 | 41824313 | PubTator, text mining | PubMed |
| Polarization-Specific Macrophage-Derived Extracellular Vesicles: Molecular Cargo, Tumor Microenvironment Remodeling, and Therapeutic Opportunities. | Int J Nanomedicine | 2026 | 41810004 | PubTator, text mining | PubMed |
| Assessing the contributions of noncoding RNAs in acute myeloid leukemia. | Blood Neoplasia | 2026 | 41798679 | PubTator, text mining | PubMed |
| Identification of multigene predictors of prognosis in patients with ovarian cancer. | iScience | 2026 | 41767263 | PubTator, text mining | PubMed |
| Microglia-Neuron Crosstalk: An Intimate Molecular Conversation in Neurodegeneration. | Int J Mol Sci | 2026 | 41752147 | PubTator, text mining | PubMed |
| MMTV-like Viruses and Human Breast Cancer: Evidence for Causality. | Curr Issues Mol Biol | 2026 | 41751420 | PubTator, text mining | PubMed |
| Identification of the Philadelphia-like subgroup in Turkish pediatric patients with acute lymphoblastic leukemia. | Ann Hematol | 2026 | 41739208 | PubTator, text mining | PubMed |
| Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer. | J Natl Cancer Cent | 2026 | 41738031 | PubTator, text mining | PubMed |
| Distinct molecular pathways leading to dosage-dependent temozolomide resistance in GBM stem cells. | Cancer Cell Int | 2026 | 41736030 | PubTator, text mining | PubMed |
| Cardiovascular and metabolic outcomes of GH replacement therapy in adults with GH deficiency - gender gaps. | Pituitary | 2026 | 41718895 | PubTator, text mining | PubMed |
| Single-cell multiomic atlas of healthy pediatric bone marrow reveals age-dependent differences in lineage differentiation driven by stromal signaling. | Nat Immunol | 2026 | 41703319 | PubTator, text mining | PubMed |
| Connexin 32 constrains a mesenchymal-like switch in differentiated urothelium and luminal cancers. | Life Sci Alliance | 2026 | 41702673 | PubTator, text mining | PubMed |
| Obesity- and tumor-derived signals drive cancer-associated state transitions in breast mesenchymal stromal/stem cells reprogrammed by IL1RA or JAK inhibition. | Exp Hematol Oncol | 2026 | 41645323 | PubTator, text mining | PubMed |
| miR-194-5p targets SOCS2 to predict pegIFNα treatment response in HBeAg-positive chronic hepatitis B patients. | Virol J | 2026 | 41645267 | PubTator, text mining | PubMed |
| Suppressor of cytokine signaling (SOCS) proteins in human retroviral infections. | Mol Biol Rep | 2026 | 41642494 | PubTator, text mining | PubMed |
| From Serendipity to Strategy: Rationalizing Molecular Glue Discovery and Proximity-Induced Pharmacology through Chemical Biology. | J Am Chem Soc | 2026 | 41622634 | PubTator, text mining | PubMed |
| In vitro generated macrophages reflect the immunosuppressive phenotype of in vivo glioblastoma-associated macrophages. | Oncoimmunology | 2026 | 41582518 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Emerging frontiers in the mitochondrial regulation of dendritic cell biology. | Redox Biol | 2026 | 41564795 | PubTator, text mining | PubMed |
| SH2scan: Mapping SH2 Domain-Ligand Binding Selectivity for Inhibitors and Degraders. | J Med Chem | 2026 | 41543922 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8835/papers?page=2